论文部分内容阅读
目的:观察参麦注射液联合多巴酚丁胺治疗难治性心力衰竭的疗效。方法:34例难治性心力衰竭患者随机分为治疗组和对照组。对照组在常规治疗的基础上加多巴酚丁胺。治疗组在对照组的基础上加用参麦注射液。结果:治疗组LVEF增加,总有效率为88.88%,对照组总有效率56.25%,2组疗效相比差异有显著性(P<0.05)。结论:参麦注射液联合多巴酚丁胺能显著改善难治性心力衰竭患者心功能。
Objective: To observe the curative effect of Shenmai injection combined with dobutamine on refractory heart failure. Methods: Thirty-four patients with refractory heart failure were randomly divided into treatment group and control group. The control group was given dobutamine on the basis of routine treatment. The treatment group added Shenmai injection on the basis of the control group. Results: The LVEF of the treatment group increased, the total effective rate was 88.88%, the control group, the total effective rate was 56.25%, the difference between the two groups was significant (P <0.05). Conclusion: Shenmai injection combined with dobutamine can significantly improve cardiac function in patients with refractory heart failure.